Trial intelligence / Profile preview

Cerebrolysin in Children With Traumatic Brain Injury and Cerebral Palsy

NCT02116348Phase 2Unknown

Sponsor
Ain Shams University
Start
Apr 2014
Primary completion
Apr 2016
Modality
Native Peptides
Countries
1
01

Overview

A Phase 2 trial of cerebrolysin in cerebral palsy (CP), traumatic brain injury (TBI), intellectual disability (ID), speech delay, sponsored by Ain Shams University. Status: unknown.

02

Drugs

cerebrolysin
03

Conditions

cerebral palsy (CP)traumatic brain injury (TBI)intellectual disability (ID)speech delay

Beyond the preview

Go deeper on NCT02116348.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02116348.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call